Phillip A. Sharp Innovation in Collaboration Award: Interrogating Impact of Epigenetic Modifiers on Durable Reprogramming of Exhausted CD8 T Cells in Patients with NSCLC Treated with PD-1 Blockade - Stand Up To Cancer

Blog

Posted October 9, 2019

Phillip A. Sharp Innovation in Collaboration Award: Interrogating Impact of Epigenetic Modifiers on Durable Reprogramming of Exhausted CD8 T Cells in Patients with NSCLC Treated with PD-1 Blockade

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.